<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11792">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02153606</url>
  </required_header>
  <id_info>
    <org_study_id>Walton-MSA14-GlycerinSupp</org_study_id>
    <nct_id>NCT02153606</nct_id>
  </id_info>
  <brief_title>Glycerin Suppositories for Premature Infants</brief_title>
  <official_title>Do Glycerin Suppositories Decrease the Time to Full Enteral Feeds in Premature Infants? A Pilot Study for a Multicenter Randomized Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McMaster Surgical Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      All premature babies have problems with feeding and nutrition. Some can develop a
      life-threatening bowel infection necrotizing enterocolitis. This can result in the need for
      emergency surgery, loss of bowel, lifelong feeding problems, and death. Giving premature
      babies glycerin suppositories may be one way to stimulate the digestive tract and help
      prevent these problems. To see if this treatment works, the investigators need to study
      hundreds of premature babies in a large trial involving multiple hospitals. The purpose of
      this project is to carry out a small study first and make sure that the larger trial is
      feasible. The investigators will invite approximately 30 premature babies from the Neonatal
      Intensive Care Unit at McMaster University Medical Centre to participate in this study over
      a 6-month period. The investigators will focus on feasibility issues, including cost,
      safety, and rate of participation. This will allow us to rigorously test our study protocol
      and lay the groundwork for the larger study involving multiple hospitals.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2014</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Time to full enteral feeds</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome for the multicentre trial will be time in days to full enteral feeding (defined as 150 mL/kg/day).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cost</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>percentage of eligible infants enrolled</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Randomization rate</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>percentage of participants randomized</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of infants reaching the primary endpoint of full enteral feeds</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feeding volume on day 14 of life (in mL/kg)</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days to complete meconium evacuation</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of parenteral nutrition</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of necrotizing colitis</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of line sepsis</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with treatment regimen</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Feeding Intolerance in Premature Infants</condition>
  <arm_group>
    <arm_group_label>Glycerin Suppository</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Suppository</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glycerine Suppository</intervention_name>
    <description>The treatment intervention will be a 250 mg glycerin suppository placed in the rectum once daily starting 48-72 hours after birth.</description>
    <arm_group_label>Glycerin Suppository</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham Suppository</intervention_name>
    <description>Sham suppositories will be created by partially dissolving a 250 mg glycerin suppository in a cup of water and placed in the diaper. This intervention works as a non-invasive placebo to maintain blinding.</description>
    <arm_group_label>Sham Suppository</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age &lt;32 weeks

          -  OR

          -  Birth weight &lt;1500 grams

        Exclusion Criteria:

          -  Congenital gastrointestinal anomalies

          -  Congenital abdominal wall anomalies (i.e., gastroschisis or omphalocele)

          -  Surgery within 48 hours of birth

          -  Vasopressors

          -  Prostaglandins

          -  Confirmed or suspected coagulopathy

          -  Thrombocytopenia (platelet count&lt;50)

          -  Neutropenia (absolute neutrophil count&lt;0.5)

          -  Culture-proven sepsis

          -  Parent or legal guardian unable to understand English
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J M Walton, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia Pemberton, MSc, PhD(c)</last_name>
    <phone>9055212100</phone>
    <phone_ext>76692</phone_ext>
    <email>pemberj@mcmaster.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>McMaster University Medical Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://fhs.mcmaster.ca/mpsrc/</url>
    <description>McMaster Pediatric Surgery Research Collaborative</description>
  </link>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 29, 2014</lastchanged_date>
  <firstreceived_date>May 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glycerin Suppositories</keyword>
  <keyword>Glycerol</keyword>
  <keyword>Enteral Nutrition</keyword>
  <keyword>Enterocolitis, Necrotizing</keyword>
  <keyword>Infant, Premature</keyword>
  <keyword>Meconium</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glycerol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
